Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Yu. Samsonov"'
Autor:
Valentina Yu. Myachikova, Alexey L. Maslyanskiy, Olga M. Moiseeva, Margarita L. Schedrova, Alina N. Egorova, Еkaterina G. Ponomar, Mikhail Yu. Samsonov
Publikováno v:
Терапевтический архив, Vol 96, Iss 09, Pp 892-900 (2024)
Aim. To evaluate the long-term safety and efficacy of goflkicept treatment in patients with idiopathic recurrent pericarditis (IRP). Materials and methods. This report presents the interim analysis of an ongoing open-label extension (OLE) clinical
Externí odkaz:
https://doaj.org/article/b05eb9ec1ac34696b30bb4daa7622294
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 3, Pp 262-279 (2024)
Autoimmunity is a pathological process associated with a violation of immunological tolerance to normal structural components of the body (autoantigens), associated with the predominance of active (adaptive) immunity and manifested by hyperproduction
Externí odkaz:
https://doaj.org/article/7b81332e885b4385851242eb44dd3651
Autor:
E. V. Arkhipov, V. A. Zaika, S. V. Kuzmin, D. Yu. Samsonov, M. D. Nefedieva, K. R. Zhuravskaya
Publikováno v:
Acta Biomedica Scientifica, Vol 9, Iss 1, Pp 136-141 (2024)
The aim. To present a clinical case of surgical treatment of parasitic invasion of the vitreous body caused by dirofilaria.Material and methods. One patient with intraocular dirofilariasis got operated underwent surgical treatment including vitrectom
Externí odkaz:
https://doaj.org/article/df0560866c22469c8e6a05d36984c35d
Autor:
R. A. Oseshnyuk, A. G. Nikiforova, A. Yu. Boroduleva, P. D. Sobolev, S. A. Lesnichuk, B. B. Garyaev, A. A. Abramova, V. G. Mozgovaya, O. V. Filon, A. V. Zinkovskaya, A. N. Dolgorukova, E. K. Khanonina, V. G. Ignatiev, M. Yu. Samsonov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 1, Pp 62-71 (2023)
Nirmatrelvir is an antiviral drug that, in combination with ritonavir, is an effective agent for the etiotropic therapy of patients with mild to moderate COVID-19.The aim of the study was to evaluate bioequivalence of the generic drug nirmatrelvir А
Externí odkaz:
https://doaj.org/article/11bc49e419f5407797e34dd4a47e6eb1
Autor:
Svetlana A. Lebedeva, Pavel A. Galenko-Yaroshevsky (Jr.), Mikhail Yu. Samsonov, Arkadiy B. Erlich, Anait V. Zelenskaya, Arus G. Margaryan, Maria Yu. Materenchuk, Iaroslav R. Arshinov, Yuriy V. Zharov, Olga V. Shelemekh, Izabella G. Lomsadze, Tatiana A. Demura
Publikováno v:
Research Results in Pharmacology, Vol 9, Iss 1, Pp 25-39 (2023)
Introduction: In the course of evolution, humans developed a number of complex multi-step wound healing mechanisms which limit the infectious agents access to the bloodstream, protect the organism from blood loss, and restore skin integrity. The proc
Externí odkaz:
https://doaj.org/article/ac684d692811453f9bde60be1546cee4
Autor:
V. B. Vasilyuk, A. Yu. Boroduleva, P. D. Sobolev, A. G. Nikiforova, V. G. Mozgovaya, O. V. Filon, A. V. Zinkovskaya, V. G. Ignatiev, M. Yu. Samsonov, I. S. Kozlova, E. K. Khanonina
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 6, Pp 562-572 (2023)
Molnupiravir is one of the drugs for the etiotropic therapy of a new coronavirus infection COVID-19. It has confirmed its clinical efficacy in the treatment of patients with mild and moderate COVID-19, including those who are at high risk of progress
Externí odkaz:
https://doaj.org/article/91d7a9f6654b4e59a0ac406a9eb82ad6
CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19
Autor:
E. V. Tavlueva, E. V. Zernova, M. P. Kutepova, N. E. Kostina, V. S. Lesina, D. R. Mould, K. Ito, A. V. Zinchenko, A. N. Dolgorukova, M. V. Nikolskaya, M. S. Lemak, O. V. Filon, M. Yu. Samsonov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 10, Iss 5, Pp 460-471 (2022)
The aim of the article is to study pharmacokinetic characteristics of intravenous olokizumab in patients with moderate COVID-19 to relieve a hyperinflammation syndrome.Materials and methods. The pharmacokinetic study was conducted as a part of a phas
Externí odkaz:
https://doaj.org/article/96b8864adb544463a121630b4d6598a5
Autor:
E. V. Shipaeva, O. V. Filon, A. V. Zintchenko, G. A. Shipunov, A. A. Dmitrieva, M. S. Lemak, S. A. Grishin, E. I. Trofimets, K. L. Kryshen, L. I. Kozlovskaya, A. S. Lunin, V. D. Apolokhov, S. F. Barbashov, Ya. V. Lavrovsky, M. Yu. Samsonov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 414-434 (2022)
Finding effective and safe medicines to fight SARS-CoV-2 infection is an urgent task. RPH-137 is an original trap fusion protein against SARS-CoV-2 virus. It comprises the angiotensin-converting enzyme type 2 extracellular domain and the human IgG1 F
Externí odkaz:
https://doaj.org/article/b6498fb9f9704919973eae259a4a5c4e
Autor:
E. S. Kuvardin, D. Yu. Andreev, P. A. Yastrebov, V. Yu. Myachikova, D. V. Bukhanova, D. V. Karpova, K. N. Malikov, M. Yu. Samsonov, A. L. Maslyanskiy
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 5, Pp 603-608 (2022)
Treatment algorithms for systemic sclerosis have not been completely developed. Effectivity of medications are usually used in clinical practice has a low level of evidence. Therefore, it is necessary to find a new treatment approaches for this nosol
Externí odkaz:
https://doaj.org/article/74c94962383a46af9b50fe955058831b
Autor:
E. L. Nasonov, M. Yu. Samsonov
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 280-298 (2022)
According to modern concepts, human immune-mediated inflammatory diseases (IMIDs), depending on the prevailing mechanisms of immunopathogenesis, are divided into two main categories – autoimmune and autoinflammatory.At the same time, both autoimmun
Externí odkaz:
https://doaj.org/article/b8af1bc3439d4d0b8d3bbe9f69b9fdab